Antenatal betamethasone regimen for women at risk of preterm birth

Lancet. 2022 Aug 20;400(10352):541-543. doi: 10.1016/S0140-6736(22)01527-6.

Authors

Nir Melamed¹, Elizabeth Asztalos²

Affiliations

¹ Division of Maternal-Foetal Medicine, Department of Obstetrics and Gynaecology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON M4N 3M5, Canada. Electronic address: nir.melamed@sunnybrook.ca.
² Department of Newborn & Developmental Paediatrics, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON M4N 3M5, Canada.

PMID: 35988553
DOI: 10.1016/S0140-6736(22)01527-6

No abstract available

Publication types

Comment

MeSH terms

Betamethasone* / therapeutic use
Clinical Protocols
Female
Gestational Age
Glucocorticoids
Humans
Infant, Newborn
Pregnancy
Premature Birth* / prevention & control

Substances

Glucocorticoids
Betamethasone